Catalyst Pharmaceuticals, Inc. (CPRX)
收市後：
| 前收市價 | 15.05 |
| 開市 | 15.13 |
| 買盤 | 15.16 x 200 |
| 賣出價 | 15.23 x 200 |
| 今日波幅 | 14.97 - 15.52 |
| 52 週波幅 | 11.09 - 17.77 |
| 成交量 | |
| 平均成交量 | 1,335,014 |
| 市值 | 1.794B |
| Beta 值 (5 年，每月) | 0.88 |
| 市盈率 (最近 12 個月) | 24.13 |
| 每股盈利 (最近 12 個月) | 0.63 |
| 業績公佈日 | 2024年5月08日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 26.71 |
ZacksCatalyst Pharmaceutical (CPRX) Reports Next Week: Wall Street Expects Earnings Growth
Catalyst (CPRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
InvestorPlaceDirt-Cheap Delights: 3 Discounted Stocks That Could Triple by 2026
Investing in discounted stocks for big gains is a time-tested strategy. Although short-term market fluctuations may capture the attention of many, companies with sustainable growth prospects often prove to be the most lucrative investments over time. Focusing on businesses with competitive advantages, healthy financials and products customers love can position investors to benefit from compounding long-term growth. These companies often have a consistent revenue growth track record and a clear v
Insider MonkeyJim Cramer’s 10 Favorite Healthcare Stock Picks in 2024
In this article, we will take a detailed look at Jim Cramer’s 10 Favorite Healthcare Stock Picks in 2024. For a quick overview of such stocks, read our article Jim Cramer’s 5 Favorite Healthcare Stock Picks in 2024. Jim Cramer kicked off 2024 with a positive note for the healthcare sector, saying in a program in January that the […]
